Gene · 55869
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Repurposing of neprilysin inhibitor 'sacubitrilat' as an anti-cancer drug by modulating epigenetic and apoptotic regulators. | Sci Rep | 2023 | 37336927 | PubTator, text mining | PubMed |
| Low avidity circulating SARS-CoV-2 reactive CD8+ T cells with proinflammatory TEMRA phenotype are associated with post-acute sequelae of COVID-19. | Front Microbiol | 2023 | 37333646 | PubTator, text mining | PubMed |
| Chemoproteomic target deconvolution reveals Histone Deacetylases as targets of (R)-lipoic acid. | Nat Commun | 2023 | 37322067 | PubTator, text mining | PubMed |
| Oculofaciocardiodental syndrome caused by a novel BCOR variant. | Hum Genome Var | 2023 | 37308473 | PubTator, text mining | PubMed |
| HDAC inhibitors enhance the anti-tumor effect of immunotherapies in hepatocellular carcinoma. | Front Immunol | 2023 | 37304265 | PubTator, text mining | PubMed |
| Non-oncology drug (meticrane) shows anti-cancer ability in synergy with epigenetic inhibitors and appears to be involved passively in targeting cancer cells. | Front Oncol | 2023 | 37274234 | PubTator, text mining | PubMed |
| Optimization and Deoptimization of Codons in SARS-CoV-2 and Related Implications for Vaccine Development. | Adv Sci (Weinh) | 2023 | 37267926 | PubTator, text mining | PubMed |
| Elevated expression of histone deacetylase HDAC8 suppresses arginine-proline metabolism in necrotizing enterocolitis. | iScience | 2023 | 37260741 | PubTator, text mining | PubMed |
| Correlating Basal Gene Expression across Chemical Sensitivity Data to Screen for Novel Synergistic Interactors of HDAC Inhibitors in Pancreatic Carcinoma. | Pharmaceuticals (Basel) | 2023 | 37259439 | PubTator, text mining | PubMed |
| An Understanding of Mechanism-Based Approaches for 1,3,4-Oxadiazole Scaffolds as Cytotoxic Agents and Enzyme Inhibitors. | Pharmaceuticals (Basel) | 2023 | 37259401 | PubTator, text mining | PubMed |
| Introducing HDAC-Targeting Radiopharmaceuticals for Glioblastoma Imaging and Therapy. | Pharmaceuticals (Basel) | 2023 | 37259375 | PubTator, text mining | PubMed |
| The relationship between the Hippo signaling pathway and bone metastasis of breast cancer. | Front Oncol | 2023 | 37256184 | PubTator, text mining | PubMed |
| Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies. | Signal Transduct Target Ther | 2023 | 37244925 | PubTator, text mining | PubMed |
| Valproate-Induced Metabolic Syndrome. | Biomedicines | 2023 | 37239168 | PubTator, text mining | PubMed |
| Computational Insights into Natural Antischistosomal Metabolites as SmHDAC8 Inhibitors: Molecular Docking, ADMET Profiling, and Molecular Dynamics Simulation. | Metabolites | 2023 | 37233699 | PubTator, text mining | PubMed |
| The epigenetic regulatory mechanisms of ferroptosis and its implications for biological processes and diseases. | MedComm (2020) | 2023 | 37229485 | PubTator, text mining | PubMed |
| Genetic diagnosis of fetal microcephaly at a single tertiary center in China. | Front Genet | 2023 | 37229200 | PubTator, text mining | PubMed |
| HDAC8 as an emerging target in drug discovery with special emphasis on medicinal chemistry. | Future Med Chem | 2023 | 37227732 | PubTator, text mining | PubMed |
| The genetics of autism and steroid-related traits in prenatal and postnatal life. | Front Endocrinol (Lausanne) | 2023 | 37223033 | PubTator, text mining | PubMed |
| Aqueous Extract of Cinnamon (Cinnamomum spp.): Role in Cancer and Inflammation. | Evid Based Complement Alternat Med | 2023 | 37215636 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55869/papers?page=19